Trial intelligence / Profile preview

Lipoic Acid Supplementation in IVF

NCT03023514Phase 4Completed

Sponsor
Lo.Li. Pharma
Start
Mar 2015
Primary completion
Jun 2016
Countries
1
01

Overview

Phase 4, randomised, open-label trial (2 arms), sponsored by Lo.Li. Pharma. Primary endpoint: Number of implants per cycle. Started Mar 2015; status: completed.

Beyond the preview

Go deeper on NCT03023514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03023514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call